Long-term medication use coded with Z79.85 (GLP-1 injectable) or Z79.84 (SGLT2 oral)
All suspected adverse reactions to Mounjaro should be reported, especially: Serious reactions, regardless of whether they are well-recognised Reactions resulting in hospitalisation or prolonged hospitalisation Suspected reactions causing congenital abnormalities Any reaction not previously documented in the Summary of Product Characteristics Reports can be submitted online at www.mhra.gov.uk/yellowcard , via the Yellow Card app, or by telephone
standard obesity coverage eliminated January 1, 2026
They tell you to use the code if the patient is using an injectable non-insulin antidiabetic drug such as Trulicity or Victoza and any other injectable GLP-1 receptor agonist, in addition to insulin, coded with Z79.4 ( Long term (current) use of insulin ), or oral diabetes drugs, such as metformin, coded to Z79.84 ( Long term (current) use of oral hypoglycemic drugs )
Not all GLP-1s are on every states preferred formulary
A denial isnt final
